🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting products of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, risking fines, legal action or prison.

Platform Reaction and Material Removal

Based on TikTok, the platform has removed problematic material and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Trading Operations

Research also found groups with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Product Information and Pricing

Inside these groups, messages display black plastic packages with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially significant health risks”.